Guillermo Garcia-Manero, MD

Dr. Garcia-Manero is Chief of the Section of Myelodysplastic Syndromes, Deputy Chair of Translational Research, and a Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.

Articles by Guillermo Garcia-Manero, MD

Guillermo Garcia-Manero, MDMDS | February 8, 2024
The panel discusses forward-looking thoughts for the treatment of low-risk MDS.
Guillermo Garcia-Manero, MDMDS | February 8, 2024
The panel talks about the use of transplant for patients with low-risk myelodysplastic syndromes.
Guillermo Garcia-Manero, MDMDS | February 8, 2024
The panel discusses other treatments undergoing research for MDS, including imetelstat and KER-050.
Guillermo Garcia-Manero, MDMDS | February 8, 2024
The panel shared their thoughts on real-world data of luspatercept presented at ASH 2023.
Guillermo Garcia-Manero, MDMDS | February 8, 2024
The panel addresses continued MDS research needs.
Guillermo Garcia-Manero, MDMDS | February 8, 2024
The panel discusses appropriate treatment selection based on patient mutation status and comorbidities.
Guillermo Garcia-Manero, MDMDS | February 8, 2024
The panel shares their thoughts on the full analysis of the COMMANDS study.